^
CANCER:

Pancreatic Adenocarcinoma





Show legend
Group by Gene:
Include preclinical:

5-fluorouracil
0
Thymidylate synthase inhibitor
capecitabine
5-fluorouracil + capecitabine
1
DNA synthesis inhibitor
cisplatin + gemcitabine
gemcitabine
2
DNA synthesis inhibitor, Bcl2 inhibitor, Tubulin inhibitor
cisplatin + gemcitabine + albumin-bound paclitaxel
gemcitabine + albumin-bound paclitaxel
3
EGFR inhibitor
erlotinib
4
PD1 inhibitor, CTLA4 inhibitor
nivolumab + ipilimumab
5
Thymidylate synthase inhibitor, Topoisomerase I inhibitor
5-fluorouracil + irinotecan
6
PARP inhibitor
rucaparib
olaparib
pembrolizumab
7
PD1 inhibitor
toripalimab-tpzi
dostarlimab-gxly
8
TrkB receptor inhibitor, TrkC kinase inhibitor, TrkA receptor inhibitor
larotrectinib
9
ZG16B inhibitor
PBP1510
10
MEK inhibitor
trametinib
selumetinib
11
KRAS G12C inhibitor
sotorasib
adagrasib
12
RET inhibitor
selpercatinib
pralsetinib
13
PD1 inhibitor, PARP inhibitor
pembrolizumab + olaparib
14
MEK inhibitor, BRAF inhibitor
trametinib + dabrafenib
15
HER2 inhibitor, EGFR inhibitor
trastuzumab + erlotinib
FOLFIRINOX
GTX
FOLFOX
16
Chemotherapy
FOLFIRI
OFF
NALIRIFOX
CAPOX
LV5FU2
17
Folate analog, Thymidylate synthase inhibitor, Topoisomerase I inhibitor
5-fluorouracil + leucovorin calcium + nanoliposomal irinotecan
18
DNA synthesis inhibitor, Thymidylate synthase inhibitor
gemcitabine + capecitabine
19
DNA synthesis inhibitor, Folate analog, Thymidylate synthase inhibitor
gemcitabine + 5-fluorouracil + leucovorin calcium
20
Folate analog, Thymidylate synthase inhibitor
5-fluorouracil + leucovorin calcium
21
TrkB receptor inhibitor, TrkC kinase inhibitor, ROS1 inhibitor, TrkA receptor inhibitor, ALK inhibitor, JAK2 inhibitor, TNK2 inhibitor
entrectinib
22
HER2 inhibitor, DNA synthesis inhibitor, EGFR inhibitor
trastuzumab + erlotinib + gemcitabine
23
MEK inhibitor, EGFR inhibitor
erlotinib + selumetinib
24
Phospholipase A2 inhibitor, DNA synthesis inhibitor, Immunomodulator, Bcl2 inhibitor, Tubulin inhibitor
gemcitabine + albumin-bound paclitaxel + hydroxychloroquine
25
ROS1 inhibitor, PTPN11 inhibitor, ALK inhibitor
lorlatinib + PF-07284892
26
ERK2 inhibitor, ERK1 inhibitor
ASN007
27
KRAS G12D inhibitor
MRTX1133
28
MEK1 inhibitor
cobimetinib
29
Alkylating agent
STAR-001
No biomarker
BRCA2 mutation
BRCA2 1153insT
TMB-H
KRAS G12C
KRAS G12R
KRAS mutation
KRAS G12D
KRAS G13D
MSI-H/dMMR
NTRK3 fusion
PALB2 mutation
RET fusion
SMAD4 deletion
EGFR expression
EGFR exon 19 mutation
SMAD4 positive
CDH1 expression
TP53 mutation
BRCA1 mutation
SPARC overexpression
ACTA2 overexpression
MMP2 overexpression
STAT3 overexpression
SEL1L-NTRK1 fusion
PD-L1 expression + TMB-H + FANCA deletion
BRAF V600E
HER-2 expression
NTRK1 fusion
NTRK2 fusion
BRCA2 mutation + CHEK2 mutation
BRCA1 mutation + TMB-H
MSI-H/dMMR + TMB-H
GOPC-ROS1 fusion + CTNNB1 S45F
KRAS G12V + TP53 mutation + APC mutation
GemPred signature
PTGR1 elevation + HRD
WFDC3 overexpression
FAM83D overexpression